Home
Corporate Profile
Technology & Research
Investors
Glossary
Contact Us
Clinical Development Strategy
Perseis Therapeutics
Business Development
Board of Directors
Management
Consultants
Corporate Governance
Neurosciences Program
Metabolism/Cancer Program
Motiva™ (nefiracetam)
NNZ-2566
NNZ-2591
NNZ-3006
NNZ-8000
Announcements
Analyst Reports and Articles
2010 Announcements
2009 Announcements
2008 Announcements
2007 Announcements
2006 Announcements
2005 Announcements
Employment Opportunities
Corporate Governance
Share Trading Policy (PDF, 0.04MB)
Code of Conduct (PDF, 0.03MB)
Corporate Governance Statement (PDF, 0.08MB)
©2008 Neuren Pharmaceuticals Limited